Therefore, we have planned to conduct this case–control study to assess the presence of GPX1 Pro198Leu polymorphism in Rwandan population to determine whether this polymorphism is associated with the risk of developing breast cancer in Rwandan patients. Here, GPX1 is linked to breast carcinoma.